Drugs for Ceroid Lipofuscinosis, Neuronal, 5 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 57)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Paclitaxel |
Approved, Vet_approved |
Phase 3 |
|
33069-62-4 |
36314 |
Synonyms:
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
5Β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7 Epi taxol
7-Epipaclitaxel
7-Epi-paclitaxel
7-epipaclitaxel|Abraxane® (albumin-bound suspension)|Taxol®
7-Epitaxol
7-Epi-taxol
ABI-007
ABRAXANE
Anzatax
BMS 181339-01
BMS-181339-01
Bris taxol
CAPXOL
CYCLOPAX
DHP 107
|
EBETAXEL
Epitaxol
GENETAXYL
GENEXOL
INTAXEL
LIPOPAC
MBT 0206
MITOTAX
NK 105
NSC-125973
Onxol
PACITAXEL
PACLITAXEL
Paclitaxel, (4 alpha)-isomer
Paxceed
Paxene
PLAXICEL
Praxel
QW-8184
TAXALBIN
TAXOL
TAXOL 100
Taxol a
Taxol, bris
Vascular Wrap
Xorane
YEWTAXAN
|
|
2 |
|
Vaccines |
|
Phase 3 |
|
|
|
3 |
|
Heptavalent Pneumococcal Conjugate Vaccine |
|
Phase 3 |
|
|
|
4 |
|
Immunologic Factors |
|
Phase 3 |
|
|
|
5 |
|
Albumin-Bound Paclitaxel |
|
Phase 3 |
|
|
|
6 |
|
Entrectinib |
Approved, Investigational |
Phase 2 |
|
1108743-60-7 |
25141092 |
Synonyms:
ENTRECTINIB
N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide
N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide
|
NMS-e628
RXDX-101
RXDX-101ENTRECTINIB
|
|
7 |
|
Atezolizumab |
Approved, Investigational |
Phase 2 |
|
1380723-44-3 |
|
Synonyms:
ANTI-PDL1
ANTI-PD-L1
ATEZOLIZUMAB
MPDL3280A
|
MPDL-3280A
RG-7446
TECENTRIQ
|
|
8 |
|
Trametinib |
Approved |
Phase 2 |
|
871700-17-3 |
11707110 |
Synonyms:
GSK 1120212
GSK1120212
GSK-1120212
GSK1120212|GSK1120212B|GSK212|JTP 74057|Mekinist®|trametinib dimethyl sulfoxide
GSK1120212B
GSK212
JTP 74057
|
JTP-74057
MEKINIST
TMT212
TRAMETINIB
TRAMÉTINIB
TRAMETINIB DIMETHYL SULFOXIDE
TRAMETINIBUM
|
|
9 |
|
Pralsetinib |
Approved, Investigational |
Phase 2 |
|
2097132-94-8 |
129073603 |
Synonyms:
(1R,4R)-N-[(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)imino]-1,6-dihydropyrimidin-2-yl}cyclohexane-1-carboximidate
BLU-667
BLU-667|BLU667|Gavreto®
|
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
PRALSETINIB
|
|
10 |
|
Vemurafenib |
Approved |
Phase 2 |
|
918504-65-1 |
42611257 |
Synonyms:
BRAF(V600E) KINASE INHIBITOR RO5185426
N-[3-[[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]-2,4-DIFLUOROPHENYL]-1-PROPANESULFONAMIDE
PLX 4032
PLX4032
PLX-4032
PLX4032|RG7204|Zelboraf®
RG7204
|
RG-7204
RO-5185426
RO-51-85426
VEMURAFENIB
Vémurafénib
Vemurafenibum
Zelboraf
|
|
11 |
|
Pertuzumab |
Approved |
Phase 2 |
|
380610-27-5 |
|
Synonyms:
2C4 ANTIBODY
2C4|Omnitarg® (obsolete trade name)|Perjeta®
Immunoglobulin G1, anti-(human v (receptor)) (human-mouse monoclonal 2C4 heavy chain), disulfide with human-mouse monoclonal 2C4 kappa-chain, dimer
LS-185920
MOAB 2C4
MONOCLONAL ANTIBODY 2C4
|
OMNITARG
OMNITARG PERJETA
PERJETA
PERTUZUMAB
RG-1273
RHUMAB-2C4
|
|
12 |
|
Trastuzumab |
Approved, Investigational |
Phase 2 |
|
180288-69-1 |
|
Synonyms:
4D5V8
ABP 980
ABP-980
ANTI HER2
D5v8|Herceptin®|R-597
DMB-3111 (TRASTUZUMAB BIOSIMILAR)
EG12014
EG-12014
HERCEPTIN
IG GAMMA-1 CHAIN C REGION
KADCYLA
|
R-597
RHUMAB HER2
SYD977
SYD-977
TRASTUZUMAB
TRASTUZUMAB BETA
trastuzumab-anns
trastuzumab-dkst
trastuzumab-dttb
trastuzumab-pkrb
trastuzumab-qyyp
|
|
13 |
|
Dabrafenib |
Approved, Investigational |
Phase 2 |
|
1195765-45-7 |
44462760 |
Synonyms:
DABRAFENIB
DRB436
GSK2118436
GSK-2118436
|
GSK2118436|GSK2118436A|Tafinlar®
GSK2118436a
GSK-2118436A
TAFINLAR
|
|
14 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
15 |
|
Protein Kinase Inhibitors |
|
Phase 2 |
|
|
|
16 |
|
Caffeine |
Approved |
|
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
17 |
|
Ethanol |
Approved |
|
|
64-17-5 |
702 |
Synonyms:
[CH2Me(OH)]
[OEtH]
1-Hydroxyethane
ABLYSINOL
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethylalkohol
Alcare hand degermer
Alcohol
Alcohol (ethyl)
Alcohol anhydrous
Alcohol denatured
ALCOHOL DETERMINATION--ALCOHOL
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Dehydrated
Alcohol, denatured
ALCOHOL, DILUTED
Alcohol, ethyl
Alcohol, grain
ALCOHOL, RUBBING
Alcohols
Alcool ethylique
Alcool éthylique
Alcool etilico
Algrain
Alkohol
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
B3324
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C2H5OH
Caswell No. 426
Colamine
Cologne spirit
Cologne spirits
Dehydrated alcohol
Dehydrated ethanol
Denatured alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Desinfektol el
Diluted alcohol
Distilled spirits
DRINKING ALCOHOL
E1510
Envision Conditioner Pdd 9020
ETA
Etanol
|
Etanolo
ETHANOL
éthanol
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol, Silent Spirit
Ethicap
Ethyl alc
Ethyl alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl hydroxide
Ethylol
Ethylolamine
EtOH
FEMA NO. 2419
Fermentation alcohol
Glycinol
Grain alcohol
Hinetoless
HSDB 531
Hydroxyethane
Infinity pure
Jaysol
Jaysol S
Lux
METHYLATED MINERAL
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
NCI-C03134
NSC-85228
PM-6193-200
Potato alcohol
Punctilious ethyl alcohol
Pyro
Reagent Alcohol
Silent spirit
SPIRIGEL
Spirit
Spirits OF wine
Spiritus vini
Spirt
SURG
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
USAF EK-1597
VODKA
|
|
18 |
|
Warfarin |
Approved |
|
|
81-81-2, 129-06-6 |
54678486 |
Synonyms:
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
4oh-Coumarin deriv.
aldo Brand OF warfarin sodium
Aldocumar
Antigen brand OF warfarin sodium
Apotex brand OF warfarin sodium
apo-Warfarin
Arab rat death
Arab rat deth
Athrombin
Athrombine-K
Athrombin-K
Bailly brand OF warfarin sodium
Boots brand OF warfarin sodium
Bristol-myers squibb brand OF warfarin sodium
Brumolin
Choice
Compound 42
CO-Rax
Coumadin
Coumadin Tabs
Coumadin®|Marevan®|panwarfin
Coumadine
Coumafen
Coumafene
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-tox
D-CON
delta-CON
Dethmor
Dethnel
Dicusat e
DL-3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
Eastern states duocide
Estedi brand OF warfarin sodium
fasco Fascrat powder
Frass-ratron
Genpharm brand OF warfarin sodium
Gen-warfarin
Goldshield brand OF warfarin sodium
Jantoven
Killgerm sewarin P
Kumader
Kumadu
Kumatox
Kypfarin
Latka 42
Liqua-tox
Maag rattentod cum
Marevan
|
Mar-frin
Martin'S mar-frin
Maveran
Mouse pak
NSC-59813
PANWARFIN
Place-pax
Potassium, warfarin
Prothromadin
Rat & mice bait
Rat and mice bait
Rat-alpha-way
Rat-a-way
Rat-beta-gon
Rat-b-gon
Rat-gard
Rat-kill
Rat-mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-ola
Ratorex
Ratox
Ratoxin
Ratron
Ratron g
Rats-NO-more
Ratten-koederrohr
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rat-trol
Rattunal
RAX
RCR Grey squirrel killer concentrate
Rodafarin
Rodafarin c
ro-Deth
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
Sakarat
Sewarin
Sodium, warfarin
Sofarin
Solfarin
Sorexa plus
Spray-trol brand roden-trol
Tedicumar
Temus W
Tintorane
Tox-hid
Twin light rat away
Vampirinip II
Vampirinip III
Waran
Warf 42
Warfant
Warfarat
WARFARIN
Warfarin Plus
Warfarin potassium
Warfarin Q
Warfarin sodium
Warfarina
Warfarine
Warficide
Warfilone
Zoocoumarin
|
|
19 |
|
Infliximab |
Approved |
|
|
170277-31-3 |
|
Synonyms:
ABP 710
BOW015
CA2
CA2 ????
IG GAMMA-1 CHAIN C REGION
INFLECTRA
INFLIXIMAB
Infliximab (genetical recombination)
|
Infliximab-abda
Infliximab-axxq
Infliximab-dyyb
Infliximab-qbtx
NI-071
REMICADE
REMSIMA
TA-650
|
|
20 |
|
Adalimumab |
Approved, Experimental |
|
|
331731-18-1 |
|
Synonyms:
ADALIMUMAB
ADALIMUMAB (GENETICAL RECOMBINATION)
ADALIMUMAB BETA
adalimumab-adaz
adalimumab-adbm
adalimumab-afzb
adalimumab-atto
adalimumab-bwwd
adalimumab-fkjp
AVT-02
BI695501
CT-P17
D2E7
FKB327
|
FKB-327
GP2017
HLX03
HLX-03
HUMIRA
Humira Pen
IG GAMMA-1 CHAIN C REGION
LU200134
LU-200134
M923
MSB11022
MSB-11022
ZRC3197
ZRC-3197
|
|
21 |
|
Vedolizumab |
Approved |
|
|
943609-66-3 |
|
Synonyms:
ENTYVIO
Entyvio®|LDP-02|LDP02|MLN-0002|MLN-002|MLN002
LDP-02
|
MLN-0002
MLN-02
VEDOLIZUMAB
|
|
22 |
|
Ustekinumab |
Approved, Investigational |
|
|
815610-63-0 |
|
Synonyms:
CNTO-1275
STELARA
STELERA
|
|
|
23 |
|
Golimumab |
Approved |
|
|
476181-74-5 |
|
Synonyms:
|
24 |
|
Estradiol |
Approved, Investigational, Vet_approved |
|
|
50-28-2 |
5757 |
Synonyms:
(+)-3,17B-ESTRADIOL
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17BETA)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(17Î’)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
(1S,10R,11S,14S,15S)-15-METHYLTETRACYCLO[8.7.0.0^{2,7}.0^{11,15}]HEPTADECA-2,4,6-TRIENE-5,14-DIOL
(8R,9S,13S,14S,17S)-13-METHYL-6,7,8,9,11,12,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHRENE-3,17-DIOL
[<sup>3</sup>H]-estradiol|[<sup>3</sup>H]-estrogen|[<sup>3</sup>H]E2|[<sup>3</sup>H]estradiol
13B-METHYL-1,3,5(10)-GONATRIENE-3,17B-OL
17 beta Estradiol
17 beta Oestradiol
17 beta-Estradiol
17 beta-Oestradiol
17b Oestradiol
17b-Estra-1,3,5(10)-triene-3,17-diol
17B-ESTRADIOL
17BETA OESTRADIOL
17BETA-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17BETA-ESTRADIOL
17BETA-OESTRADIOL
17B-OESTRADIOL
17Î’ oestradiol
17Î’-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
17β-estradiol
17Î’-OESTRADIOL
3,17B-DIHYDROXYESTRA-1,3,5(10)-TRIENE
3,17B-ESTRADIOL
3,17-EPIDIHYDROXYESTRATRIENE
ADGYN ESTRO
AERODIOL
AGOFOLLIN
ALFATRADIOL
ALORA
ALTRAD
AMNESTROGEN
AQUADIOL
AQUAGEN
BARDIOL
BEDOL
B-ESTRADIOL
BETA-ESTRADIOL
CIS-ESTRADIOL
CLIMADERM
CLIMARA
CLIMARA PRO
COMPUDOSE
CORPAGEN
Delestrogen
DELTA-ESTRADIOL
DELTA-OESTRADIOL
DEPO-ESTRADIOL
DERMESTRIL
DERMESTRIL 100
DERMESTRIL 25
DERMESTRIL 50
DERMESTRIL SEPTEM 25
DERMESTRIL SEPTEM 50
DERMESTRIL SEPTEM 75
DESTRADIOL
D-ESTRADIOL
DIHYDROFOLLICULAR HORMONE
DIHYDROFOLLICULIN
DIHYDROMENFORMON
DIHYDROTHEELIN
DIHYDRO-THEELIN
DIHYDROXYESTRIN
DIMENFORMON
DIOGYN
DIOGYNETS
DIVIGEL
D-OESTRADIOL
E2
E2|estrogen|oestrodiol|oestrogen
E-CYPIONATE
ELESTRIM
ELESTRIN
ELLESTE SOLO
ELLESTE SOLO MX 40
ELLESTE SOLO MX 80
ENCORE
EPIESTRIOL 50
ESCLIM
ESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
ESTRACE
ESTRADERM
ESTRADERM MX 100
ESTRADERM MX 25
ESTRADERM MX 50
ESTRADERM MX 75
ESTRADERM TTS
ESTRADERM TTS 100
ESTRADERM TTS 25
ESTRADERM TTS 50
ESTRADIOL
Estradiol 17 alpha
Estradiol 17 beta
Estradiol 17beta
Estradiol anhydrous
ESTRADIOL HEMIHYDRATE
Estradiol hemihydrate, (17 alpha)-isomer
Estradiol monohydrate
Estradiol orion brand
Estradiol valerate
Estradiol valeriante
|
Estradiol, (-)-isomer
Estradiol, (+-)-isomer
Estradiol, (16 alpha,17 alpha)-isomer
Estradiol, (16 alpha,17 beta)-isomer
Estradiol, (17-alpha)-isomer
Estradiol, (8 alpha,17 beta)-(+-)-isomer
Estradiol, (8 alpha,17 beta)-isomer
Estradiol, (9 beta,17 alpha)-isomer
Estradiol, (9 beta,17 beta)-isomer
Estradiol, monosodium salt
Estradiol, sodium salt
Estradiol-17 alpha
Estradiol-17 beta
Estradiol-17b
ESTRADIOL-17BETA
ESTRADIOL-17-BETA
Estradiol-17β
ESTRADIOLUM
ESTRADOT
ESTRALDINE
ESTRASORB
ESTRING
ESTRING VAGINAL RING
ESTROCLIM
ESTROCLIM 50
ESTROGEL
ESTROGEL HBF
ESTROGEN
ESTROVITE
EVAMIST
EVOREL
EVOREL 100
EVOREL 25
EVOREL 50
EVOREL 75
FEMATRIX 40
FEMATRIX 80
FEMESTRAL
FEMOGEN
FEMPATCH
FEMSEVEN 100
FEMSEVEN 50
FEMSEVEN 75
FOLLICYCLIN
GELESTRA
GINOSEDOL
GVNODIOL
GYNERGON
GYNODIOL
GYNOESTRYL
GYNOGEN
IMVEXXY
INNOFEM
LAMDIOL
MACRODIOL
MENOREST
MENOREST 37.5
MENOREST 50
MENOREST 75
MENORING 50
MENOSTAR
MINIVELLE
NORDICOL
Novartis pharmaceuticals brand OF estradiol
NSC-20293
NSC-9895
OESCLIM
OESTERGON
OESTRA-1,3,5(10)-TRIENE-3,17B-DIOL
OESTRADIOL
OESTRODIOL
OESTROGEL
OESTROGEN
OESTROGLANDOL
Orion brand OF estradiol
OVAHORMON
OVASTEROL
OVASTEVOL
OVOCYCLIN
OVOCYLIN
PERLATANOL
PRIMOFOL
PROFOLIOL
PROFOLIOL B
PROGYNON
Progynon depot
PROGYNON DH
Progynon-depot
Progynova
PROGYNOVA TS
SANDRENA
SANDRENA 1
SYNDIOL
SYSTEN
VAGIFEM
VAGIFEM 18
VAGIFEM 8
VIVELLE
VIVELLE-DOT
WC3011
WC-3011
ZUMENON
Î’-estradiol
|
|
25 |
|
Polyestradiol phosphate |
Approved |
|
|
28014-46-2 |
|
Synonyms:
(17-beta)-Estra-1,3,5(10)-triene-3,17-diol polymer with phosphoric acid
ESTRADIOL PHOSPHATE
Estradiol phosphate polymer
ESTRADURIN
Fosfato de poliestradiol
LEO-114
Oestradiol phosphate polymer
|
Phosphate de polyestradiol
Poly(estradiol phosphate)
POLYEST PHOS
POLYESTRADIOL PHOS PHOSPHATE
POLYESTRADIOL PHOSPHATE
Polyestradioli phosphas
|
|
26 |
|
Norethisterone |
Approved |
|
|
68-22-4 |
199472 6230 |
Synonyms:
(-)-Gallocatechin gallic acid
(-)-Gallocatechin-3-O-gallate
(-)-Gallocatechin-3-O-gallic acid
(-)-Gallocatechol gallate
(-)-Gallocatechol gallic acid
(17a)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17alpha)-17-Ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(17-alpha)-17-Hydroxy-19-norpregn-4-en-20-yn-3-one
(17Α)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoic acid)
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(2S,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoic acid
17a-Ethinyl-19-nortestosterone
17a-Ethinylestra-4-en-17b-ol-3-one
17a-Ethynyl-17b-hydroxy-19-norandrost-4-en-3-one
17a-Ethynyl-17-hydroxy-4-estren-3-one
17-a-Ethynyl-17-hydroxy-4-estren-3-one
17a-Ethynyl-19-nor-4-androsten-17b-ol-3-one
17a-Ethynyl-19-norandrost-4-en-17b-ol-3-one
17-a-Ethynyl-19-norandrost-4-en-17-b-ol-3-one
17a-Ethynyl-19-nortestosterone
17-a-Ethynyl-19-nortestosterone
17a-Ethynyl-4-estren-17-ol-3-one
17-a-Ethynyl-4-estren-17-ol-3-one
17alpha-Ethinyl-17alpha-ethinyl-19-nortestosterone
17alpha-Ethinyl-19-nortestosterone
17alpha-Ethinylestra-4-en-17beta-ol-3-one
17alpha-Ethynyl-17beta-hydroxy-19-norandrost-4-en-3-one
17-alpha-Ethynyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-17beta-hydroxyestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-4-estren-3-one
17-alpha-Ethynyl-17-hydroxy-4-estren-3-one
17alpha-Ethynyl-17-hydroxyest-4-en-3-one
17alpha-Ethynyl-17-hydroxy-estr-4-en-3-one
17alpha-Ethynyl-19-nor-4-androsten-17beta-ol-3-one
17alpha-Ethynyl-19-norandrost-4-en-17beta-ol-3-one
17-alpha-Ethynyl-19-norandrost-4-en-17-beta-ol-3-one
17alpha-Ethynyl-19-nortestosterone
17-alpha-Ethynyl-19-nortestosterone
17alpha-Ethynyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-4-estren-17-ol-3-one
17-alpha-Ethynyl-4-estren-17-ol-3-one
17alpha-Pregn-4-en-20-yn-3-one
17beta-Hydroxy-17alpha-ethynylestr-4-en-3-one
17beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-beta-Hydroxy-19-norpregn-4-en-20-yn-3-one
17b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-b-Hydroxy-19-norpregn-4-en-20-yn-3-one
17-Ethinyl-19-nor-testosterone
17-Ethynyl-17beta-hydroxyestr-4-en-3-one
17-Ethynyl-17-hydroxyestr-4-en-3-one (acd/name 4.0)
17-Ethynyl-19-nortestosterone
17-Hydroxy-(17alpha)-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-17-alpha-19-norpregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-alpha-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-a-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one
17-Hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one
17Α-ethinyl-19-nortestosterone
17Α-ethinylestra-4-en-17β-ol-3-one
17Α-ethynyl-17-hydroxy-4-estren-3-one
17-Α-ethynyl-17-hydroxy-4-estren-3-one
17Α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one
17Α-ethynyl-19-nor-4-androsten-17β-ol-3-one
17Α-ethynyl-19-norandrost-4-en-17β-ol-3-one
17-Α-ethynyl-19-norandrost-4-en-17-β-ol-3-one
17Α-ethynyl-19-nortestosterone
17-Α-ethynyl-19-nortestosterone
17Α-ethynyl-4-estren-17-ol-3-one
17-Α-ethynyl-4-estren-17-ol-3-one
17Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
17-Î’-hydroxy-19-norpregn-4-en-20-yn-3-one
19-Nor-17a-ethynyl-17b-hydroxy-4-androsten-3-one
19-Nor-17-a-ethynyl-17-b-hydroxy-4-androsten-3-one
19-Nor-17a-ethynylandrosten-17b-ol-3-one
19-Nor-17-a-ethynylandrosten-17-b-ol-3-one
19-Nor-17a-ethynyltestosterone
19-Nor-17-a-ethynyltestosterone
19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one
19-Nor-17-alpha-ethynyl-17-beta-hydroxy-4-androsten-3-one
19-Nor-17alpha-ethynylandrosten-17beta-ol-3-one
19-Nor-17-alpha-ethynylandrosten-17-beta-ol-3-one
|
19-Nor-17alpha-ethynyltestosterone
19-Nor-17-alpha-ethynyltestosterone
19-Nor-17-ethinyltestosterone
19-Nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one
19-Nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one
19-Nor-17α-ethynylandrosten-17β-ol-3-one
19-Nor-17-α-ethynylandrosten-17-β-ol-3-one
19-Nor-17α-ethynyltestosterone
19-Nor-17-α-ethynyltestosterone
19-Nor-ethindrone
19-Norethinyltestosterone
19-Norethisterone
4-Estren-17a-ethynyl-17b-ol-3-one
4-Estren-17alpha-ethynyl-17beta-ol-3-one
4-Estren-17α-ethynyl-17β-ol-3-one
ACTIVELLA
Anhydrohydroxynorprogesterone
Anovule
AYGESTIN
Camila
COMBIPATCH
Conceplan
Conludaf
Conludag
ENT
ent-Gallocatechin 3-gallic acid
ERRIN
Ethinyl-19-nortestosterone
Ethinylnortestosterone
Ethynylnortestosterone
FEMHRT
Gallocatechin gallate
Gallocatechin-3-gallate
Gestest
HEATHER
INCASSIA
JENCYCLA
Menzol
Micronett
Micronor
MICRONOR HRT
Micronor®|norethindrone|Noriday®
Micronovum
Mini-pe
Mini-pill
Minovlar
Monogest
NEA713
NET
Nor QD
Noralutin
Norcolut
Norcolute
Noresthisterone
NORETHIDRONE
Norethindrone
Norethindrone, (1 beta)-isomer
Norethisteron
Norethisterone
Noréthistérone
Norethisteronum
Norethyndron
Norethynodrone
Noretisterona
Norfor
Norgestin
Noriday
Norlutate
Norluten
Norlutin
Norluton
Normapause
Norpregneninlone
Norpregneninolone
Nor-q.d.
NorQD
Nor-QD
NSC-9564
Primolut N
Primolut-N
Proluteasi
SC-4640
Utovlan
Utovlar
|
|
27 |
|
Clodronic acid |
Approved, Investigational, Vet_approved |
|
|
10596-23-3 |
25419 |
Synonyms:
(Dichloromethylene)bisphosphonate
(Dichloromethylene)bisphosphonic acid
(Dichloromethylene)diphosphonate
(Dichloromethylene)diphosphonic acid
(Dichloro-phosphono-methyl)-phosphonate
(Dichloro-phosphono-methyl)-phosphonic acid
Acid, clodronic
Acid, dichloromethanediphosphonic
Acide clodronique
Acide Clodronique [INN-French]
Acido clodronico
Acido Clodronico [INN-Spanish]
Acidum clodronicum
Acidum Clodronicum [INN-Latin]
Biphosphonate, dichloromethylene
Bonefos
Bonefos®|Clasteon ®|clodronate|Loron®
CL2MDP
Clasteon
Clodronate
Clodronate disodium
Clodronate sodium
|
Clodronic acid
Clodronsaeure
CLODRONSÄURE
Dichloromethane diphosphonate
Dichloromethanediphosphonate
Dichloromethanediphosphonic acid
Dichloromethylene biphosphonate
Dichloromethylene diphosphonate
Dichloromethylene-1,1-bisphosphonate
Dichloromethylene-1,1-bisphosphonic acid
Dichloromethylene-1,1-diphosphonate
Dichloromethylene-1,1-diphosphonic acid
Dichloromethylenebisphosphonate
Dichloromethylidene diphosphonate
Dichloromethylidene diphosphonic acid
Diphosphonate, dichloromethane
Diphosphonate, dichloromethylene
Disodium, clodronate
Loron
Ostac
Sodium, clodronate
|
|
28 |
|
Nicotine |
Approved |
|
|
54-11-5 |
942 89594 |
Synonyms:
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(−)-nicotine
(-)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+)-Nicotine
(+-)-Nicotine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(RS)-Nicotine
(S)-(−)-nicotine
(S)-(-)-Nicotine
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine
(S)-3-(N-Methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridal)-pyrrolidine
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-Methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
a -N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
a-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
Bitartrate, nicotine
Black Leaf
Black Leaf 40
Campbell's Nico-Soap
Commit
delta-Nicotine
Destruxol
Destruxol Orchid Spray
DL-Tetrahydronicotyrine
D-Nicotine
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
Habitrol
L(−)-nicotine
L(-)-Nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
|
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Niagara P.A. Dust
NICABATE
Nicocide
Nicoderm
NICODERM CQ
Nico-Dust
Nico-Fume
NICOPASS
NICOPATCH
Nicorette
NICORETTE INVISI
Nicorette Plus
Nicorette®|Nicotrol®
Nicotin
Nicotina
Nicotine
Nicotine alkaloid
Nicotine betadex
Nicotine bitartrate
Nicotine polacrilex
Nicotine tartrate
NICOTINELL CLASSIC
NICOTINELL SUPPORT
NICOTINELL TTS 10
NICOTINELL TTS 20
NICOTINELL TTS 30
NICOTROL
NICOTROL INHALER
NICOTROL NS
Nic-Sal
Nikotin
Nikotyna
NIQUITIN
NIQUITIN CLR
NIQUITIN MINIS CHERRY
NIQUITIN MINIS MINT
NIQUITIN MINIS ORANGE
NIQUITIN MINT
NIQUITIN PRE-QUIT
NIQUITIN STRIPS MINT
Ortho N-4 Dust
Ortho N-5 Dust
PROSTEP
R)-(+)-Nicotine
STOPPERS
STUBIT
Tartrate, nicotine
Tendust
|
|
29 |
|
Titanium dioxide |
Approved |
|
|
13463-67-7 |
|
Synonyms:
dióxido de titanio
óxido de titanio(4)
|
|
|
30 |
|
Ergocalciferol |
Approved, Nutraceutical |
|
|
50-14-6 |
5280793 |
Synonyms:
(+)-Vitamin D2
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(E,2R,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(E,1R,4R)-1,4,5-TRIMETHYLHEX-2-ENYL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,3AS,4E,7AR)-1-[(2R,3E,5R)-5,6-DIMETHYLHEPT-3-EN-2-YL]-7A-METHYL-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3b,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(3Î’,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,secoergosta-5,7,10(19)-ol
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3ah)-indanylidene]ethylidene]-cyclohexanol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
Activated ergosterol
beta-Ol
Buco-D
Calciferol
CALCIFEROL IN ARACH OIL
Calciferols
Calciferon 2
CALTRATE
Condacaps
Condocaps
Condol
Crtron
Crystallina
D2, Vitamin
Daral
D-Arthin
Davitamon D
Davitin
Decaps
Dee-osterol
Dee-ron
Dee-ronal
Dee-roual
delta-Arthin
Deltalin
delta-Tracetten
De-rat concentrate
Deratol
Detalup
D-FORTE
Diactol
Divit urto
Doral
Drisdol
D-Tracetten
ECIFEROL D2
Ercalciol
|
Ergocalciferol
ERGOCALCIFÉROL
Ergocalciferol oil
Ergocalciferols
Ergocalciferolum
ERGO-D2
ERGORAL D2
Ergorone
Ergosterol activated
Ergosterol irradiated
Ertron
Fortodyl
Geltabs
Hi-deratol
Infron
Irradiated ergosta-5,7,22-trien-3beta-ol
LANES
Metadee
Mina D2
Mulsiferol
Mykostin
Novovitamin-D
NSC-62792
Oleovitamin D
OLEOVITAMIN D, SYNTHETIC
Oleovitamin D2
Osteil
Ostelin
OSTO-D2
Radiostol
Radstein
Radsterin
Rodine C
Shock-ferol
Shock-ferol sterogyl
Sterogyl
STEROGYL 15H
STEROGYL-15
Synthetic vitamin D
Uvesterol D
Uvesterol-D
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in oil
VITAMIN D
Vitamin D 2
Vitamin D2
Vitamina D2
Vitavel-D
|
|
31 |
|
Cholecalciferol |
Approved, Nutraceutical, Vet_approved |
|
|
67-97-0, 1406-16-2 |
5280795 10883523 |
Synonyms:
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
(3Î’,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL
7-DEHYDROCHOLESTEROL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
ACCRETE D3
ACIFEROL D3
ACTIVATED
Activated 7-dehydrocholesterol
ADCAL-D3
ARACHITOL
AVITICOL
BIOLIFE VITAMIN D3
BIO-VITAMIN D3
CACIT D3
CALCEOS
CALCICHEW D3
CALCICHEW D3 FTE
CALCICHEW D3 ONCE DAILY
CALCI-D
Calciferol
Calciol
CALDRINK D3
CALFOVIT D3
CC
Cholecalciferol
CHOLECALCIFEROL D3
Cholecalciferols
Cholecalciferolum
COLECAL D3
Colecalciferol
Colecalciferolum
COLEKAL-D3
COLEVIT D3
CUBICOLE D3
D3 LEMON MELTS
D3-50
D3-VIGANTOL
DEKRISTOL
DELSTEROL
Delta-D
DEPARAL
DESUNIN
DEVARON
Dihydrocholesterol
DLUX 400
D-MAX
D-TRACETTEN
|
D-VIT3
EBIVIT
E-D3
EVACAL D3
FERACOL
FULTIUM DAILY D3
FULTIUM-D3
GRANUVIT D3
HUX D3
INVITA D3
ISO D3
KORA LIQUID
MICRO-DEE
NATECAL D3
NATURE'S REMEDY VITAMIN D3
NEO-D
NPHD3
NSC-375571
Oleovitamin D3
OSTEOCAPS D3
PLENACHOL
PRO D3
PRO D3 FOLIC
PRO D3 FORTE
PROVITINA
QUINTOX
RICKETON
ROYALVIT D3
STEXEROL-D3
STIVIT-D3
SUNVIT-D3 1,000
SUNVIT-D3 10,000
SUNVIT-D3 2,000
SUNVIT-D3 20,000
SUNVIT-D3 3,000
SUNVIT-D3 400
SUNVIT-D3 5,000
SUNVIT-D3 50,000
SUNVIT-D3 800
SYNERVIT-D3
THEICAL D-3
THORENS
TRIVITAN
VIDDE-3-HYDROSOL
VI-DE3
VIDEKHOL
VIGANTOL
VIGANTOLETTEN
VIGANTOLETTEN 500
VIGORSAN
VIT D3 STREULI
VITA-D3
VITAMIN D
Vitamin D 3
VITAMIN D ASSAY SYSTEM SUITABILITY
Vitamin D NOS
Vitamin D, unspecified form
Vitamin D3
Vitamin D-3
VITINC DAN-DEE-3
ZYMAD
δ-D
|
|
32 |
|
Lobeline |
Investigational |
|
|
90-69-7 |
|
Synonyms:
(-)-LOBELINE
ALPHA-LOBELINE
ALPHA-LOBELINE HCL
|
Lobelina
Lobeline
LOBELINE HCL
|
|
33 |
|
Insulin, Globin Zinc |
|
|
|
|
|
34 |
|
Insulin |
|
|
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
35 |
|
Anticoagulants |
|
|
|
|
|
36 |
|
Estrogens |
|
|
|
|
|
37 |
|
Estradiol 3-benzoate |
|
|
|
|
|
38 |
|
Estradiol 17 beta-cypionate |
|
|
|
|
|
39 |
|
Hormone Antagonists |
|
|
|
|
|
40 |
|
Contraceptives, Oral, Hormonal |
|
|
|
|
|
41 |
|
Contraceptives, Oral |
|
|
|
|
|
42 |
|
Contraceptive Agents |
|
|
|
|
|
43 |
|
Trisequens |
|
|
|
|
|
44 |
|
Norethindrone Acetate |
|
|
|
|
541197 |
Synonyms:
14-Ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadec-6-en-14-yl acetic acid
Aygestin
NORETHIDRONE ACETATE
NORETHINDRONE ACETATE
Norethindrone acetate, (17alpha)-(+-)-isomer
Norethindrone acetate, (17alpha)-isomer
|
Norethindrone acetic acid
Norethisterone acetate
Norlutate
NSC-22844
SH-420
|
|
45 |
|
Antidepressive Agents |
|
|
|
|
|
46 |
|
Acidophilus |
|
|
|
|
|
47 |
|
Vitamin D2 |
|
|
|
|
3249 |
Synonyms:
Calciferols
D2, Vitamin
Ergocalciferol
|
Ergocalciferols
Vitamin D 2
Vitamin D2
|
|
48 |
|
Ergocalciferols |
|
|
|
|
|
49 |
|
Analgesics |
|
|
|
|
|
50 |
|
Vitamins |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 62)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy Trial in Finnish Children of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Pneumococcal Serotypes in the Vaccines |
Completed |
NCT00378417 |
Phase 3 |
|
2 |
Paclitaxel Eluting Stent in Long Superficial Femoral Artery Obstruction: a Prospective, Randomized Comparison With Bypass Surgery Using PTFE Graft in a Finnish Multicenter Study |
Recruiting |
NCT01450722 |
Phase 3 |
|
3 |
A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease |
Completed |
NCT01907087 |
Phase 1, Phase 2 |
|
4 |
A Phase 2, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Intracerebroventricular BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease |
Completed |
NCT02678689 |
Phase 2 |
|
5 |
Phase I/IIa Gene Transfer Clinical Trial for Variant Late Infantile Neuronal Ceroid Lipofuscinosis, Delivering the CLN6 Gene by Self-Complementary AAV9 |
Completed |
NCT02725580 |
Phase 1, Phase 2 |
|
6 |
A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease |
Completed |
NCT02485899 |
Phase 1, Phase 2 |
|
7 |
Direct CNS Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human CLN2 cDNA to Children With LINCL With Uncommon Genotypes and/or Moderate to Severe Impairment |
Completed |
NCT01414985 |
Phase 1, Phase 2 |
|
8 |
A Phase 1/2 Intracerebroventricular and Intravitreal Administration of NGN-101 for Treatment of Neuronal Ceroid Lipofuscinosis (NCL) Subtype 5 (CLN5) Disease |
Recruiting |
NCT05228145 |
Phase 1, Phase 2 |
|
9 |
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs to Determine the Efficacy in Treatment of Advanced Cancers With a Known Molecular Profile |
Recruiting |
NCT05159245 |
Phase 2 |
Alectinib;Cobimetinib;Vismodegib;Trastuzumab+Pertuzumab;Entrectinib;Atezolizumab;Vemurafenib;Regorafenib;Apalutamide;Abemaciclib;Selpercatinib;Dabrafenib;Trametinib;Dabrafenib+Trametinib;Pralsetinib |
10 |
Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Expressing the Human CLN2 cDNA to the Brain of Children With Late Infantile Neuronal Ceroid Lipofuscinosis |
Completed |
NCT00151216 |
Phase 1 |
|
11 |
Direct CNS Administration of a Replication Deficient Adeno-associated Virus Gene Transfer Vector Serotype rh.10 Expressing the Human CLN2 cDNA to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL) |
Completed |
NCT01161576 |
Phase 1 |
|
12 |
A Phase Ib Study of the Safety and Preliminary Efficacy of Allogeneic Intracerebral Human Central Nervous System Stem Cell Transplantation in Subjects With Non-Refractory Infantile and Late Infantile Neuronal Ceroid Lipofuscinosis |
Withdrawn |
NCT01238315 |
Phase 1 |
|
13 |
Pilot Study on Oral Health Status Chairside Mouthrinse Test in Finnish Adolescents and Cost Effectiveness of the Test |
Unknown status |
NCT04139863 |
|
|
14 |
Finnish Genetic Study for Arrhythmic Events |
Unknown status |
NCT02075866 |
|
|
15 |
Finnish Tennis Elbow Trial Pilot Study |
Unknown status |
NCT02425982 |
|
|
16 |
The Prevalence of Low Back Symptoms in a Finnish Forestry Company - Effectiveness of Primary Care Interventions for Non-acute Low Back Symptoms in Occupational Health. Two Separate Randomised Controlled Trials (RCT) of Various Levels. |
Unknown status |
NCT00908102 |
|
|
17 |
Finnish Telestroke Pilot 2007-2009 |
Unknown status |
NCT01136993 |
|
|
18 |
Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability |
Unknown status |
NCT01041989 |
|
|
19 |
Implementation of Finnish Prehospital Stroke Scale (FPSS) to Emergency Medical Services - a Prospective, Multi-centre Study |
Unknown status |
NCT03520335 |
|
|
20 |
Finnish Health and Early Life Microbiota (HELMi) Longitudinal Birth Cohort |
Unknown status |
NCT03996304 |
|
|
21 |
The Glycemic and Insulinemic Responses of the Finnish Foods: Measurement and Modification |
Unknown status |
NCT01477216 |
|
|
22 |
Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis |
Completed |
NCT01035424 |
|
|
23 |
Genotype - Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis |
Completed |
NCT00151268 |
|
|
24 |
Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) |
Completed |
NCT04645537 |
|
|
25 |
Seinäjoki Adult Asthma Study: A 12-year Real-life Follow-up Study of New-onset Asthma Diagnosed at Adult Age and Treated in Primary and Specialized Care. Finnish Title: Diagnoosista Hoitotasapainoon: Voidaanko Aikuisen Astman Hoitotasapainoa Ennustaa Diagnoosivaiheen löydösten ja Astman Ilmiasun Perusteella? |
Completed |
NCT02733016 |
|
|
26 |
Groin Injuries in Finnish Contact Sports: Prospective 2-year Clinical and Magnetic Resonance Imaging Study |
Completed |
NCT02560480 |
|
|
27 |
Exposure to Remicade (Infliximab) During Pregnancy in Patients With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis and Psoriasis: a Review and Analysis of Birth Outcomes From the Swedish, Danish and Finnish Medical Birth Registers |
Completed |
NCT00658827 |
|
|
28 |
Finnish Spinal Cord Injury Study (FinSCI) |
Completed |
NCT04649814 |
|
|
29 |
Finnish-German Prospective, Observational Follow-up Study on Risk Assessment of Mortality After Myocardial Infarction |
Completed |
NCT00828698 |
|
|
30 |
Reliability and Validity of the Finnish Version of the Prothesis Evaluation Questionnaire |
Completed |
NCT02436148 |
|
|
31 |
Combining Biological Therapies in Patients With Inflammatory Bowel Disease: a Finnish Multi-centre Study. |
Completed |
NCT05135221 |
|
|
32 |
Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections; a Randomized Double-blinded Trial in Young Finnish Men |
Completed |
NCT00973583 |
|
|
33 |
Randomized Clinical Trial on the Effectts of Estradiol 2 mg + NETA 1 mg With or Without Clodronate on Bone Mineral Density and Bone Markers of Osteoporotic Postmenopausal 167 Finnish Women. |
Completed |
NCT00877097 |
|
Klodronate and Kliogest;Bonefos |
34 |
A Finnish Community Randomized Psychotherapy Effectiveness Study for Major Depression |
Completed |
NCT02314767 |
|
|
35 |
Probiotic and Respiratory and Gastrointestinal Tract Infections in Finnish Military Conscripts - a Randomized and Placebo-controlled Double-blinded Study |
Completed |
NCT01651195 |
|
|
36 |
Prevalence of Memory and Attention Disorders and Malnutrition in Hospitalized Older Adults (Muistitoimintojen ja Tarkkaavaisuuden häiriöiden ja Vajaaravitsemuksen Yleisyys iäkkäillä Sairaalahoidossa Olevilla Potilailla [Finnish]) |
Completed |
NCT03252054 |
|
|
37 |
Prevention of Musculoskeletal Injuries in Finnish Conscripts. A Cluster Randomized Controlled Trial. |
Completed |
NCT00595816 |
|
|
38 |
Reliability and Validity of the Finnish Versions of the Visual Analogue Scale Foot and Ankle and the Lower Extremity Functional Scale |
Completed |
NCT02536651 |
|
|
39 |
Tobacco Use and Incidence of SARS-CoV-2 Infection in the Finnish General Population |
Completed |
NCT04915781 |
|
|
40 |
Evidence for Validity and Reliability of the Finnish Version of the Foot and Ankle Ability Measure |
Completed |
NCT02330198 |
|
|
41 |
Nationwide Finnish Registry of Transcatheter and Surgical Aortic Valve Replacement for Aortic Valve Stenosis: FinnValve Registry |
Completed |
NCT03385915 |
|
|
42 |
Finnish Trial on Practices of Anterior Cervical Decompression and Fusion (FACADE): A Protocol for a Prospective Randomized Non-inferiority Trial Comparing Outpatient vs. Inpatient Care |
Completed |
NCT03979443 |
|
|
43 |
Finnish Elective Cardioversion for Persistent Atrial Fibrillation Study |
Completed |
NCT02850679 |
|
|
44 |
Lifestyle Intervention for Toddlers at Finnish Welfare Clinics |
Completed |
NCT01204489 |
|
|
45 |
Estimation of the Minimal Important Difference and Validation of Finnish Versions of Foot and Ankle Patient-reported Outcome Instruments |
Completed |
NCT03444441 |
|
|
46 |
Finnish Vitamin D Trial (FIND) |
Completed |
NCT01463813 |
|
|
47 |
Family Welfare Pilot Intervention Study at Finnish Welfare Clinics |
Completed |
NCT01813903 |
|
|
48 |
A Natural History and Outcome Measure Discovery Study of Variant Late Infantile Neuronal Ceroid Lipofuscinosis Type 5 (CLN5) and Variant Late Infantile Neuronal Ceroid Lipofuscinosis Type 7 (CLN7) |
Recruiting |
NCT03822650 |
|
|
49 |
Clinical and Neuropsychological Investigations in Batten Disease |
Recruiting |
NCT01873924 |
|
|
50 |
Natural History and Long Term Clinical Assessments of All Forms of Neuronal Ceroid Lipofuscinoses - Capturing Key Symptoms and Disease Progression as Part of the Independent, International NCL DEM-CHILD Patient Database |
Recruiting |
NCT04613089 |
|
|
|